Predictors of poor seroconversion and adverse events to SARS-CoV-2 mRNA BNT162b2 vaccine in cancer patients on active treatment

Tania Buttiron Webber, Nicoletta Provinciali, Marco Musso, Martina Ugolini, Monica Boitano, Matteo Clavarezza, Mauro D’Amico, Carlotta Defferrari, Alberto Gozza, Irene Maria Briata, Monica Magnani, Fortuna Paciolla, Nadia Menghini, Emanuela Marcenaro, Raffaele De Palma, Nicoletta Sacchi, Leonello Innocenti, Giacomo Siri, Oriana D’Ecclesiis, Isabella Cevasco, Sara Gandini, Andrea DeCensi